BNIP-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of BNIP-2 monoclonal antibodies for research focused on understanding BNIP-2's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BNIP-2, or Bcl-2/adenovirus E1B 19 kDa interacting protein 2, is a pro-apoptotic protein that influences cell death and survival pathways. Research has shown BNIP-2's involvement in autophagy modulation and its connection to various diseases, including cancer and neurodegenerative disorders. Understanding BNIP-2 function continues to reveal new insights about its potential as a therapeutic target. Ongoing studies explore BNIP-2's role in cellular stress responses and mitochondrial dynamics. Current research investigates how BNIP-2 interacts with other proteins in the apoptotic pathway. Researchers worldwide rely on BNIP-2 monoclonal antibodies to advance scientific understanding of cellular health and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for BNIP-2 support researchers in making meaningful contributions to cell biology and disease research.